Management of IgG4 Deficiency

Diagnostic Confirmation

The American Academy of Allergy, Asthma, and Immunology recommends that IgG4 deficiency should not be diagnosed before age 10 years, and when confirmed in older patients with recurrent infections, management follows the same principles as other IgG subclass deficiencies: aggressive antimicrobial therapy first-line, with immunoglobulin replacement therapy reserved for those with quality-of-life-impairing infections that fail antibiotic management 1
Diagnosis of IgG4 deficiency should be confirmed with at least two measurements taken at least 1 month apart showing IgG4 levels below the fifth percentile, according to the American Academy of Allergy, Asthma, and Immunology 1, 3
The American Academy of Allergy, Asthma, and Immunology suggests measuring all four IgG subclasses simultaneously when evaluating for subclass deficiency, as isolated measurements add cost without clear benefit 1, 2
Verification of normal total IgG, IgM, and IgA levels is necessary to confirm this is truly a selective subclass deficiency rather than broader hypogammaglobulinemia, as recommended by the American Academy of Allergy, Asthma, and Immunology 1, 3
Assessment of specific antibody responses to pneumococcal vaccines is crucial to determine functional antibody production, according to the American Academy of Allergy, Asthma, and Immunology 1

The American Academy of Allergy, Asthma, and Immunology recommends aggressive antibiotic treatment as the cornerstone of initial management, with longer courses of antibiotics than would be given to immunocompetent patients for acute respiratory infections 1, 2
Consideration of prophylactic antibiotics, such as amoxicillin, trimethoprim/sulfamethoxazole, or macrolides, is necessary for patients with recurrent sinopulmonary infections, as suggested by the American Academy of Allergy, Asthma, and Immunology 1, 2
Aggressive treatment of atopic disease is essential if present, as allergic inflammation predisposes to secondary respiratory infections, particularly sinusitis and otitis media, according to the American Academy of Allergy, Asthma, and Immunology 2

The American Academy of Allergy, Asthma, and Immunology recommends considering immunoglobulin replacement therapy when recurrent infections negatively affect quality of life and aggressive antibiotic therapy and prophylaxis have failed 1, 3
Intolerable side effects or hypersensitivity to antibiotics that prevent adequate antimicrobial management are indications for immunoglobulin replacement therapy, as suggested by the American Academy of Allergy, Asthma, and Immunology 1, 3
Evidence of permanent organ damage, such as bronchiectasis, is an indication for immunoglobulin replacement therapy, according to the American Academy of Allergy, Asthma, and Immunology 1

The American Academy of Allergy, Asthma, and Immunology notes that infections may wane over time even when the immunologic abnormality persists 1
The subclass abnormality itself may resolve while infections continue, as observed by the American Academy of Allergy, Asthma, and Immunology 1
Rare progression to more severe phenotypes, such as CVID, can occur later in life, requiring ongoing surveillance, according to the American Academy of Allergy, Asthma, and Immunology 1
Associated conditions, including atopy and autoimmune disease, require concurrent management, as recommended by the American Academy of Allergy, Asthma, and Immunology 1

The American Academy of Allergy, Asthma, and Immunology advises against measuring IgG subclasses routinely when total immunoglobulins and specific antibodies are normal, as this adds cost without clear benefit 1, 3, 2
Diagnosis should not be based on a single low measurement, as transient decreases can occur, according to the American Academy of Allergy, Asthma, and Immunology 1, 3
Rushing to IVIG therapy is not recommended, as the majority of patients will not have meaningful clinical response and should be managed with antimicrobials first, as suggested by the American Academy of Allergy, Asthma, and Immunology 1, 3
Assuming IgG4 deficiency is clinically significant without documented recurrent infections is not recommended, as low levels may be an incidental finding, according to the American Academy of Allergy, Asthma, and Immunology 1, 2
Awareness of secondary causes, including antiepileptic drugs, which can cause reversible IgG4 deficiency, is essential, as noted by the American Academy of Allergy, Asthma, and Immunology 1, 2

The American Academy of Allergy, Asthma, and Immunology notes that IgG4 deficiency is frequently associated with low IgG2 levels and/or low IgA levels occurring together 1, 2
Other primary immunodeficiencies, such as ataxia-telangiectasia and Wiskott-Aldrich syndrome, are associated with IgG4 deficiency, according to the American Academy of Allergy, Asthma, and Immunology 1
Secondary immunodeficiencies, including HIV/AIDS and post-hematopoietic stem cell transplantation, are associated with IgG4 deficiency, as observed by the American Academy of Allergy, Asthma, and Immunology 1